Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety: Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06171880
What this trial is testing

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Who this might be right for
Healthy Adult
Jeil Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT04102462
What this trial is testing

Test How Well Healthy Men Tolerate Different Doses of BI 764198

Who this might be right for
Healthy
Boehringer Ingelheim 52
Early research (Phase 1)Study completedNCT05325346
What this trial is testing

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Who this might be right for
Heparin-induced Thrombocytopenia
Veralox Therapeutics 12
Early research (Phase 1)Study completedNCT01289886
What this trial is testing

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 40
Early research (Phase 1)Study completedNCT06744127
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Study completedNCT00863161
What this trial is testing

Renal Impairment Study

Who this might be right for
RefluxRenal Excretion
AstraZeneca 23
Early research (Phase 1)Study completedNCT03637361
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)

Who this might be right for
Neuropathic Pain
Relmada Therapeutics, Inc. 42
Early research (Phase 1)Study completedNCT05429073
What this trial is testing

RGLS8429 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Regulus Therapeutics Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT02815488
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 118
Early research (Phase 1)Study completedNCT02502903
What this trial is testing

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Who this might be right for
Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)+1 more
Bioverativ, a Sanofi company 122
Early research (Phase 1)Study completedNCT01579461
What this trial is testing

Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Who this might be right for
PharmacokineticsHealthy SubjectsMild and Moderate Hepatic Impairment
Astellas Pharma Europe B.V. 32
Early research (Phase 1)Study completedNCT01636141
What this trial is testing

Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects

Who this might be right for
Healthy Volunteers
Olatec Therapeutics, Inc. 36
Early research (Phase 1)Study completedNCT00828646
What this trial is testing

Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese

Who this might be right for
Healthy
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT02218346
What this trial is testing

Food Effect Study of AG-221 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Agios Pharmaceuticals, Inc. 30
Early research (Phase 1)Study completedNCT03231124
What this trial is testing

Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 26
Early research (Phase 1)Study completedNCT04097938
What this trial is testing

Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 52
Early research (Phase 1)UnknownNCT06492655
What this trial is testing

To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT06361355
What this trial is testing

Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Taizhou Mabtech Pharmaceutical Co.,Ltd 128
Early research (Phase 1)Study completedNCT07054255
What this trial is testing

Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects

Who this might be right for
Healthy
Haisco Pharmaceutical Group Co., Ltd. 72
Large-scale testing (Phase 3)Study completedNCT00224484
What this trial is testing

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Who this might be right for
Herpes Simplex
GlaxoSmithKline 5,960
Next Page